Stockholm, 3 August 2023 - TIRmed Pharma is pleased to announce the appointment of Pirkko Tamsen as a new member of its Board of Directors. This strategic addition to the board further strengthens the company's leadership team and brings valuable expertise to support its growth and strategic objectives.
Pirkko Tamsen is a highly accomplished professional with an impressive track record of over 30 years in the pharmaceutical industry. She has held various leadership positions, including CEO of several small pharmaceutical companies and CRO firms, as well as positions in prominent pharmaceutical companies like Astra and Kabi. Pirkko has previously been part of the Board of Directors at Karolinska Institutet Innovations AB, Alzecure Pharma AB and Örebro University Holding AB.
Speaking on this appointment, Leo Holmgren, CEO of TIRmed Pharma, expressed excitement about the new addition to the board. "Pirkko Tamsen is an outstanding professional and has been indispensable, as a consultant to TIRmed, in advancing our development program. We are incredibly excited to have her joining now as part of the board of directors. We are confident that she will provide valuable insights, strategic guidance, and contribute to our ongoing efforts to deliver new treatments to the millions of patients suffering from inflammatory skin diseases."